As drugmakers slam Medicare price controls, Wall Street shrugs
Washington Post
Drugmakers unleashed a broadside at the Inflation Reduction Act, but most will see minimal impacts from price caps – for now.
https://www.washingtonpost.com/business/2023/08/29/medicare-drug-price-pharma-companies-stock/